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INTRODUCTION 
Escherichia coli (E. coli) is a very diverse species of 
bacteria that forms a major part of the normal intestinal 
flora.
1
 Extra intestinal Pathogenic E. coli (ExPEC) cause 
extra intestinal infections including urinary tract 
infections (UTIs), diverse intra-abdominal infections, 
pneumonia, surgical-site infections, meningitis, 
osteomyelitis, soft-tissue infections and bacteremia.
2,3
 
Uropathogenic E. coli (UPEC) strains are responsible for 
about 90% of all community-acquired UTIs and up to 
50% of all nosocomial UTI.
4
 The development of UTIs 
depends on anatomical factors, the integrity of host 
defense mechanisms, and the virulence of the infecting 
organisms.
1,5
 Antibiotic resistance is a major threat to 
public health worldwide.
6,7
 There are high prevalence of 
multi drug resistant E. coli in UTI infections against β-
Lactam groups (penicillins, cephalosporins, carbapenems 
and Monobactams) because of their ability to produce 
Extended Spectrum β-Lactamases (ESBLs).8,9 E. coli 
may acquire other antibiotic resistance traits from 
surroundings bacteria and conversely it can spread its 
resistance genes to different potential pathogens.
10
 The 
aims of this study were to determine the prevalence of 
uropathogenic E. coli among people, of both genders 
aged nine months to 63 years, referring to Zakho 
emergency hospital and private laboratories in Zakho 
city/Kurdistan Region, Iraq. Also, to study their 
resistance against antimicrobials used to treat urinary 
tract infections (UTIs) to provide data to help direct 
empirical therapy. 
 
ABSTRACT 
 
Background: Antimicrobial resistance in uropathogenic E. coli is of major concern worldwide due to its increasing 
resistance to several commonly prescribed antibiotics. The aims of this study were to determine the prevalence and to 
evaluate the presence and antibiogram pattern of uropathogenic E. coli among people in Zakho city, Iraq.  
Methods: 1120 urine samples were collected from people. Samples were screened for E. coli isolates and their 
susceptibility to different antibiotics was analyzed.  
Results: Diagnoses tests showed that only 106 (9.4%) isolates were E. coli. Females (90, 85%) were more susceptible 
to urinary tract infections (UTIs) than males (16, 15%) (p <0.05). The age 11-21 years old (23, 21.7%) was the most 
affected group (p <0.05). All isolates were resistant to penicillin, ampicillin and aztreonam. While, all these isolates 
were sensitive to imipenem and meropenem.  
Conclusions: The incidence of uropathogenic E. coli among people is comparable with reports from elsewhere. E. 
coli isolates are highly susceptible towards imipenem, and meropenem antibiotics, and highly resistant towards β-
lactam and cephalosporins antibiotics. Education programs and improving the hygienic measures are necessary to 
prevent contaminations with E. coli and minimize the use of β-lactam and cephalosporin antibiotics.  
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METHODS 
Sample collection 
A total of 1120 urine samples were collected from people 
admitting to Zakho emergency hospital and private 
laboratories in Zakho city from September 2013 to 
February 2014. Urine samples were collected from 
people directly at their arrival to the emergency hospital 
and laboratories for different reasons. Samples were 
collected from both genders aged nine months to 63 
years. Samples were transported to the laboratory within 
30 minutes to one hour then characterized using different 
conventional bacteriological and biochemical methods. 
The study was conducted with the approval of ethics 
committee in the University of Zakho, School of Science. 
Laboratory screening for E. coli isolates 
Urine samples were cultured on MacConkey agar and 
incubated for overnight at 37°C. The lactose-fermenting 
colonies were selected and sub-cultured on MacConkey 
agar to obtain a pure culture. Suspected isolated colonies 
were diagnosed and characterized using microscopical 
(Gram stain, capsule stain and motility test) and 
biochemical tests including indole test, methyl red test 
(M.R), Voges-Proskaur test (V.P), citrate utilization test, 
urease test.
11
 
Antibiotic sensitivity test 
Table 1: Antibiotics used in this study class 
antimicrobial symbol concentration. 
Class   Antimicrobial    Symbol 
Con
n 
 µg/ml 
β-lactams 
Penicillins Penicillin P 30 
Carbapenems 
Imipenem IPM 10 
Meropenem MEM 10 
Monobactams Aztreonam ATM 10 
Aminopenicillin Ampicillin  AM 25 
Cephalosporins 
Cefazolin (1G) CZ 30 
Cefuroxime 
(2G) 
CXM 30 
Ceftazidime 
(3G) 
CAZ 30 
Cefotaxime 
(3G) 
CTX 30 
   Ceftriaxone (3G) CRO 30 
 Cefepime (4G) FEP 30 
β-lactamase Inhibitors 
Amoxicillin-clavulanic AMC 20/10 
Ampicillin-Sulbactam SAM 25/5 
Piperacillin-Tazobactam TZP 20/10 
All E. coli isolates were tested against 14 different 
antimicrobial drugs (Bioanalyse, Turkey) as listed in 
Table 1. Screening for antibiotic resistance was 
performed using disc diffusion assay according to Bauer, 
et al.
12
 Bacterial suspensions were prepared in 1.0 ml of 
sterile saline solution. 0.5 ml of suspensions was spread 
on Mueller-Hinton agar plates and then incubated for 24 
hours. The inhibition zones were measured in comparison 
to the Clinical Laboratory Standards institute.
13
 
Statistical analysis 
 
The relationships between categorical variables were 
examined using the Chi-square test with significance set 
at a p value of <0.05 using Minitab 15 software (Minitab 
Ltd., Coventry, UK). 
RESULTS 
Biochemical characterization of E. coli isolates 
A total of 1120 urine samples were submitted for analysis 
and culture. Biochemical and morphological 
characterization of lactose fermenting isolates was carried 
out.
11,14
 These biochemical tests were capable to give a 
clear cut differentiation between E. coli and other gram 
negative bacteria species. A total of 205 (18.3%) isolates 
showed positive growth on MacConkey agar. Lactose 
fermenting and lactose non fermenting colonies were 171 
(83.4%) and 34 (16.6%) respectively. Among these 205 
isolates, 106 (51.7%) were identified as E. coli. 
The occurrence of E. coli isolates according to gender 
and age 
The prevalence of E. coli uropathogens was analysed 
according to person's gender and age group. Among the 
205 positive growth on MacConkey agar, 88 (43%) were 
from males and 117 (57%) from females. The prevalence 
of E. coli among people was significantly higher in 
females than males 90 (85%) and 16 (15%) respectively, 
(p <0.05). People were divided into 5 groups according to 
their age (Table 2). Our study showed that the prevalence 
of urinary pathogens was not consistent across all age 
groups. Overall, it is found that the percentage of E. coli 
isolates was high in people older than 11 years and 
younger than 44 years of age and lower percentage in 
people younger 11 years and older than 44 years. 
Statistical analysis showed that the incidence of infection 
with uropathogenic E. coli was significant (p <0.05) 
among age group of 11-21 years old (23, 21.7%). 
Antibiotic susceptibility test 
All E. coli isolates (106) were tested for their antibiotic 
susceptibility pattern against 14 antibiotics which include 
different β-lactam and cephalosporin groups. All isolates 
were 100% resistant to β-lactam antibiotics penicillin, 
ampicillin and aztreonam, whereas, all isolates were 
100% susceptible to β- lactam antibiotics imipenem and 
meropenem (Table 3).  
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Table 2: Incidence of E. coli isolates among people 
according to gender and age. 
Total and 
percentage  
of infection (%) 
No. of infected 
patients of both 
genders 
Age groups  
(year) 
Female Male 
11 (10.4) 9 2 9 months-10 
23 (21.7)* 21 2 11-21 
44 (41.5) 37 7 22-33 
18 (17.0) 15 3 34-44 
10 (9.4) 8 2 45-63 
106 (100) 90 16 Total 
* P< 0.05 
Table 3: Antimicrobial susceptibility among 
uropathogenic E. coli. 
Antibiotics 
No. of 
resistant 
isolates (%) 
No. of 
sensitive 
isolates (%) 
 
-lactam 
P 106 (100) 0 (0.0) 
AM 106 (100) 0 (0.0) 
ATM 106 (100) 0 (0.0) 
IPM 0 (0.0) 106 (100) 
MEM 0 (0.0) 106 (100) 
 
Cephalosporins 
CZ 55 (52) 51 (48.1) 
CXM 55 (52) 51 (48.1) 
CAZ 55 (52) 51 (48.1) 
CTX 55 (52) 51 (48.1) 
CRO 55 (52) 51 (48.1) 
FEP 55 (52) 51 (48.1) 
Beta-lactamase 
inhibitors 
AMC 18 (17) 88 (83) 
SAM 73 (68.9) 33 (31.1) 
TZP 44 (41.5) 62 (58.5) 
This study revealed that only 55 (52%) E. coli isolates 
were resistant for all four cephalosporin generations 
including cefazolin, cefuroxime, ceftazidime, cefotaxime, 
ceftriaxone and cefepime. These results indicate that 
these isolates are ESBLs producers. E. coli isolates 
showed variable patterns in their susceptibility against the 
antibiotics containing β-lactamase inhibitors as it is 
shown in Table 3. 
DISCUSSION 
Urinary tract infections (UTIs) are the second most 
common infectious presentation in community medical 
practice. Worldwide, about 150 million people are 
diagnosed with UTI each year.
15
 About 80% of UTIs are 
caused by E. coli. In this study, a total of 205 isolates 
showed positive growth on MacConkey agar. Lactose 
fermenting and lactose non-fermenting colonies were 171 
(83.4%) and 34 (16.6%) respectively. Studies from 
different parts of Iraq and worldwide showed that lactose 
fermenters E. coli and Klebsiella were the most common 
pathogens associated with UTIs.
16-18
 Non-lactose 
fermenting were found to be the least dominant 
uropathogens causing UTIs like Pseudomonas, S. aureus, 
Proteus, Enterobacter, Acinetobacter and 
Enterococcus.
19
 
Biochemical and morphological tests detected 106 
(51.7%) E. coli isolates among the 205 isolates. These 
results were in agreement with the results obtained from 
other studies conducted worldwide which approved that 
E. coli is the major pathogen that cause UTIs.
20,21
 As E. 
coli is a major normal flora in the gut and most of the 
times poor hygiene will lead to cross contamination and 
then urinary tract infections.
1,22
  
Various studies noted that uropathogenic E. coli is the 
predominant organism in females than males.
19,23
  In the 
present study, the higher rate of E. coli was found in 
females (85%) compared to (15%) males. The higher 
incidence of urinary tract infections in females is due to 
unique anatomical features of the female genitourinary 
tract, which include a shorter urethra and the more 
proximal location of the urethral meatus to the anus 
makes it easy for bacteria to ascend in the urinary tract.
24
 
Fecal-perineal-urethral contamination is the most 
probable explanation for infections caused by E. coli 
strains causing UTI in women.
25
 About 50% of women 
will experience at least one UTI in their lifetime, and of 
those about 25% will suffer from one or more recurrent 
(or relapsing) infections.
26
 UPEC isolates can also be 
transmitted via sexual activities.
27
 
E. coli was common among people aged 11-44 years. 
This result comparable to a study conducted by Kiffer, et 
al they found that the higher percentage of E. coli isolates 
in people of age group 13-60 and lower percentage in 
people younger 13 years or older than 60 years.
28
 Another 
study found that the lowest percentage of E. coli was 
among age group less than 10 years and high within the 
age group 26-36 years.
29
 In our current study a high 
percentage of Uropathogenic E. coli in people were found 
in ages (11-21) years (p<0.05). This may be due to a poor 
hygiene condition or other reasons. However, more study 
is needed to explore this result. 
Antimicrobial resistance in uropathogenic E. coli is of 
major concern worldwide due to its increasing resistance 
to several commonly prescribed antibiotics.
30
 In our 
study, E. coli isolates were various in their susceptibility 
to different antibiotics belonging to different groups. All 
isolates were 100% resistant to penicillin, ampicillin and 
aztreonam, whereas, all isolates were 100% susceptible to 
imipenem and meropenem. This results was comparable 
to different locally and worldwide studies.
31
 This high 
resistance may be due to the spontaneous and 
uncontrollable use of these antibiotics.
32
 The 
carbapenems (imipenem and meropenem) are known to 
be stable against ESBL enzymes and effective in the 
treatment of infections caused by ESBL-producing 
bacteria.
33
 The administration routes of these antibiotics 
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either intravenous or intramuscular make this group of 
limited usage by most patients.
34
 
55 (52%) E. coli isolates were resistant for all four 
cephalosporin generations. E. coli and other genera of 
gram negative bacteria possess a naturally occurring, 
chromosomally mediated β lactamase and plasmid 
mediated β-lactamase.35,36 The plasmid-mediated 
resistance had spread all over the world and into many 
different members of the Enterobacteriaceae family.
37
 In 
our study, E. coli isolates susceptibility patterns against 
the β-lactamase inhibitors was variable. These results 
were found to be in agreement with results obtained by 
Kumar et al.
38
 The addition of clavulanate significantly 
expands amoxicillin's spectrum to include penicillinase-
producing E. coli, Klebsiella spp., S. aureus, Neisseria 
gonorrhoeae, and Pseudomonas mirabilis.
39
 The efficacy 
of β-lactam-β-lactamase inhibitor combinations may be 
reduced for organisms producing multiple ESBLs.
40
 
CONCLUSION 
The incidence and causative uropathogenic E. coli are 
comparable with reports from elsewhere. Females were 
more susceptible to UTI than males. The age group of 11-
21 year was with higher percentage of E. coli. 
Uropathogenic E. coli isolates are highly susceptible 
towards imipenem, and meropenem antibiotics, and 
highly resistant towards β-lactam and cephalosporins 
antibiotics. For this reason, the prevalence of these 
pathogens and their susceptibility to antibiotics must be 
considered in the choice of treatment for UTI. 
Additionally, education programs and improving the 
hygienic measures are necessary to prevent 
contaminations and cross-infections with E. coli and 
minimize the use of β-lactam and cephalosporin 
antibiotics in order to minimize the emergence of ESBLs 
producing bacteria.  
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